Prescription drug · UNAPPROVED DRUG OTHER
Concept DHA (vitamin- mineral omega-3 supplement) NDC 52747-621
Ferrous fumarate 17.5 mg/1 + 14 more ingredients · Capsule, Liquid filled · Oral · U.S. Pharmaceutical Corporation
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 52747-621-30 | 52747062130 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (52747-621-30)Marketed from Jun 24, 2009 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Concept DHA
- Generic name (nonproprietary)
- vitamin- mineral omega-3 supplement
- Active ingredients
- Ferrous fumarate — 17.5 mg/1Iron — 17.5 mg/1Ascorbic acid — 25 mg/1Folic acid — 1 mg/1Thiamine mononitrate — 2 mg/1Riboflavin — 3 mg/1Niacin — 1.8 mg/1Calcium pantothenate — 5 mg/1Pyridoxine hydrochloride — 25 mg/1Biotin — 300 ug/1Cyanocobalamin — 12.5 ug/1Cupric sulfate — 2 mg/1Magnesium sulfate, Unspecified form — 5 mg/1Zinc sulfate, Unspecified form — 10 mg/1Omega-3-acid ethyl esters — 200 mg/1
- Dosage form
- Capsule, Liquid filled
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Analogs/Derivatives (Chemical/Ingredient)Ascorbic Acid (Chemical structure)Decreased Copper Ion Absorption (Physiologic effect)Omega-3 (Chemical structure)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Nicotinic Acids (Chemical structure)Osmotic Activity (Mechanism)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)Vitamin B 12 (Chemical structure)Vitamin B 6 (Chemical/Ingredient)
- Identifiers
- Product ID 52747-621_aaee698d-9522-49c9-afd3-d0c5d52e3ccdSPL ID aaee698d-9522-49c9-afd3-d0c5d52e3ccdSPL set ID bd2051f7-b887-46f6-8d4a-b099fcd08629UNII R5L488RY0Q, E1UOL152H7, PQ6CK8PD0R, 935E97BOY8, 8K0I04919X, TLM2976OFR, 2679MF687A, 568ET80C3D, 68Y4CF58BV, 6SO6U10H04, P6YC3EG204, LRX7AJ16DT, DE08037SAB, 89DS0H96TB, D87YGH4Z0Q
- Pharmacologic class
- Calculi Dissolution Agent; Copper Absorption Inhibitor; Nicotinic Acid; Omega-3 Fatty Acid; Osmotic Laxative; Vitamin B12; Vitamin B6 Analog; Vitamin C
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N452747062130followed by a unit qualifier and the quantityPackage 52747-0621-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS: Concept DHATM is a prescription prenatal vitamin-mineral preparation containing omega-3 fatty acid supplements designed to supply nutritional supplementation for women throughout pregnancy and during the postnatal period to lactating and non-lactating mothers. Concept DHATM may also be used to improve the nutritional status of women before conception.
Excerpt only. Read the full label for complete information.